{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:20:57Z","timestamp":1791980457223,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>GS-5734 is a monophosphate prodrug of an adenosine nucleoside analog that showed therapeutic efficacy in a non-human primate model of Ebola virus infection. It has been administered under compassionate use to two Ebola patients, both of whom survived, and is currently in Phase 2 clinical development for treatment of Ebola virus disease. Here we report the antiviral activities of GS-5734 and the parent nucleoside analog across multiple virus families, providing evidence to support new indications for this compound against human viruses of significant public health concern.<\/jats:p>","DOI":"10.1038\/srep43395","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T07:51:26Z","timestamp":1488786686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":444,"title":["GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"],"prefix":"10.1038","volume":"7","author":[{"given":"Michael K.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Arvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawahar","family":"Sudhamsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punya","family":"Shrivastava-Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Hotard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"McMullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael O.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Mackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hon C.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Perron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian S.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Cihlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"BFsrep43395_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2009.09.014","volume":"85","author":"T Cihlar","year":"2010","unstructured":"Cihlar, T. & Ray, A. S. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Res 85, 39\u201358 (2010).","journal-title":"Antiviral Res"},{"key":"BFsrep43395_CR2","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.3390\/v7102868","volume":"7","author":"AA Eltahla","year":"2015","unstructured":"Eltahla, A. A., Luciani, F., White, P. A., Lloyd, A. R. & Bull, R. A. Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance. Viruses 7, 5206\u20135224 (2015).","journal-title":"Viruses"},{"key":"BFsrep43395_CR3","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.bmcl.2012.02.105","volume":"22","author":"A Cho","year":"2012","unstructured":"Cho, A. et al. Synthesis and antiviral activity of a series of 1\u2032-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Bioorg Med Chem Lett 22, 2705\u20132707 (2012).","journal-title":"Bioorg Med Chem Lett"},{"key":"BFsrep43395_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren, T. K. et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381\u2013385 (2016).","journal-title":"Nature"},{"key":"BFsrep43395_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2014.03.011","volume":"106","author":"MK Lo","year":"2014","unstructured":"Lo, M. K., Nichol, S. T. & Spiropoulou, C. F. Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening. Antiviral Res 106, 53\u201360 (2014).","journal-title":"Antiviral Res"},{"key":"BFsrep43395_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","volume":"332","author":"JS Towner","year":"2005","unstructured":"Towner, J. S. et al. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology 332, 20\u201327 (2005).","journal-title":"Virology"},{"key":"BFsrep43395_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.virol.2015.06.013","volume":"484","author":"CG Albarino","year":"2015","unstructured":"Albarino, C. G., Wiggleton Guerrero, L., Lo, M. K., Nichol, S. T. & Towner, J. S. Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein. Virology 484, 259\u2013264 (2015).","journal-title":"Virology"},{"key":"BFsrep43395_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.virol.2013.07.038","volume":"446","author":"CG Albarino","year":"2013","unstructured":"Albarino, C. G. et al. Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate. Virology 446, 230\u2013237 (2013).","journal-title":"Virology"},{"key":"BFsrep43395_CR9","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","volume":"161","author":"CL Afonso","year":"2016","unstructured":"Afonso, C. L. et al. Taxonomy of the order Mononegavirales: update 2016. Arch Virol 161, 2351\u20132360 (2016).","journal-title":"Arch Virol"},{"key":"BFsrep43395_CR10","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1128\/JVI.02924-14","volume":"89","author":"LJ Rennick","year":"2015","unstructured":"Rennick, L. J. et al. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates. J Virol 89, 2192\u20132200 (2015).","journal-title":"J Virol"},{"key":"BFsrep43395_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/JVI.79.2.1113-1124.2005","volume":"79","author":"L Zhang","year":"2005","unstructured":"Zhang, L. et al. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79, 1113\u20131124 (2005).","journal-title":"J Virol"},{"key":"BFsrep43395_CR12","doi-asserted-by":"publisher","first-page":"10508","DOI":"10.1128\/JVI.74.22.10508-10513.2000","volume":"74","author":"LK Hallak","year":"2000","unstructured":"Hallak, L. K., Spillmann, D., Collins, P. L. & Peeples, M. E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74, 10508\u201310513 (2000).","journal-title":"J Virol"},{"key":"BFsrep43395_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.virol.2003.12.020","volume":"321","author":"S Biacchesi","year":"2004","unstructured":"Biacchesi, S. et al. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321, 247\u2013259 (2004).","journal-title":"Virology"},{"key":"BFsrep43395_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.virol.2011.05.003","volume":"417","author":"P Xu","year":"2011","unstructured":"Xu, P. et al. Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus. Virology 417, 126\u2013136 (2011).","journal-title":"Virology"},{"key":"BFsrep43395_CR15","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1128\/JVI.02501-07","volume":"82","author":"BH Bird","year":"2008","unstructured":"Bird, B. H. et al. Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J Virol 82, 2681\u20132691 (2008).","journal-title":"J Virol"},{"key":"BFsrep43395_CR16","doi-asserted-by":"publisher","first-page":"e1004879","DOI":"10.1371\/journal.ppat.1004879","volume":"11","author":"E Bergeron","year":"2015","unstructured":"Bergeron, E. et al. Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin. PLoS Pathog 11, e1004879 (2015).","journal-title":"PLoS Pathog"},{"key":"BFsrep43395_CR17","doi-asserted-by":"crossref","unstructured":"Sims, A. C. et al. The small molecule nucleoside prodrug GS-5734 exhibits broad antiviral activity against pathogenic human coronaviruses and related zoonotic strains. In 4th Antivirals Congress (Sitges, Barcelona, Spain, 2016).","DOI":"10.4172\/2327-5073.C1.023"},{"key":"BFsrep43395_CR18","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1093\/nar\/gkg916","volume":"31","author":"X Xu","year":"2003","unstructured":"Xu, X. et al. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res 31, 7117\u20137130 (2003).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep43395_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virol.2003.09.046","volume":"321","author":"E Kinsella","year":"2004","unstructured":"Kinsella, E. et al. Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment. Virology 321, 23\u201328 (2004).","journal-title":"Virology"},{"key":"BFsrep43395_CR20","doi-asserted-by":"publisher","first-page":"e0139001","DOI":"10.1371\/journal.pone.0139001","volume":"10","author":"R Jacome","year":"2015","unstructured":"Jacome, R., Becerra, A., Ponce de Leon, S. & Lazcano, A. Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic Implications. PLoS One 10, e0139001 (2015).","journal-title":"PLoS One"},{"key":"BFsrep43395_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.antiviral.2014.03.018","volume":"106","author":"LS Uebelhoer","year":"2014","unstructured":"Uebelhoer, L. S. et al. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. Antiviral Res 106, 86\u201394 (2014).","journal-title":"Antiviral Res"},{"key":"BFsrep43395_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","volume":"362","author":"BH Bird","year":"2007","unstructured":"Bird, B. H., Albarino, C. G. & Nichol, S. T. Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology 362, 10\u201315 (2007).","journal-title":"Virology"},{"key":"BFsrep43395_CR23","first-page":"493","volume":"27","author":"LJM Reed","year":"1938","unstructured":"Reed, L. J. M. H. A simple method of estimating fifty percent endpoints. Am J Hygiene 27, 493\u2013497 (1938).","journal-title":"Am J Hygiene"},{"key":"BFsrep43395_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jviromet.2008.01.016","volume":"149","author":"M Aljofan","year":"2008","unstructured":"Aljofan, M., Porotto, M., Moscona, A. & Mungall, B. A. Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus. J Virol Methods 149, 12\u201319 (2008).","journal-title":"J Virol Methods"},{"key":"BFsrep43395_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3201\/eid2103.141862","volume":"21","author":"LE Hensley","year":"2015","unstructured":"Hensley, L. E., Dyall, J., Olinger, G. G. Jr. & Jahrling, P. B. Lack of effect of lamivudine on Ebola virus replication. Emerg Infect Dis 21, 550\u2013552 (2015).","journal-title":"Emerg Infect Dis"},{"key":"BFsrep43395_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1743-422X-7-115","volume":"7","author":"CF Chiang","year":"2010","unstructured":"Chiang, C. F., Lo, M. K., Rota, P. A., Spiropoulou, C. F. & Rollin, P. E. Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA. Virol J 7, 115 (2010).","journal-title":"Virol J"},{"key":"BFsrep43395_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.antiviral.2015.10.010","volume":"125","author":"LK McMullan","year":"2016","unstructured":"McMullan, L. K. et al. The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus. Antiviral Res 125, 71\u201378 (2016).","journal-title":"Antiviral Res"},{"key":"BFsrep43395_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.antiviral.2015.05.003","volume":"120","author":"EL Mohr","year":"2015","unstructured":"Mohr, E. L. et al. Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses. Antiviral Res 120, 40\u201347 (2015).","journal-title":"Antiviral Res"},{"key":"BFsrep43395_CR29","doi-asserted-by":"publisher","first-page":"e99764","DOI":"10.1371\/journal.pone.0099764","volume":"9","author":"CF Chiang","year":"2014","unstructured":"Chiang, C. F., Albarino, C. G., Lo, M. K. & Spiropoulou, C. F. Small interfering RNA inhibition of Andes virus replication. PLoS One 9, e99764 (2014).","journal-title":"PLoS One"},{"key":"BFsrep43395_CR30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1099\/vir.0.19685-0","volume":"85","author":"K Halpin","year":"2004","unstructured":"Halpin, K., Bankamp, B., Harcourt, B. H., Bellini, W. J. & Rota, P. A. Nipah virus conforms to the rule of six in a minigenome replication assay. J Gen Virol 85, 701\u2013707 (2004).","journal-title":"J Gen Virol"},{"key":"BFsrep43395_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nmeth.2413","volume":"10","author":"NC Shaner","year":"2013","unstructured":"Shaner, N. C. et al. A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nat Methods 10, 407\u2013409 (2013).","journal-title":"Nat Methods"},{"key":"BFsrep43395_CR32","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/nar\/gkh340","volume":"32","author":"RC Edgar","year":"2004","unstructured":"Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32, 1792\u20131797 (2004).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep43395","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep43395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep43395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:22:33Z","timestamp":1671805353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep43395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,22]]}},"alternative-id":["BFsrep43395"],"URL":"https:\/\/doi.org\/10.1038\/srep43395","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]},"assertion":[{"value":"18 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors affiliated with Gilead Sciences are employees of the company and may own company stock.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43395"}}